ImmunoGen shares are trading higher after AbbVie announced it will acquire the company in a transaction valued at $31.26 per share in cash
Benzinga
2023-11-30
Views 1.2K
ImmunoGen shares are trading higher after AbbVie announced it will acquire the company in a transaction valued at $31.26 per share in cash
#1 Morning Stock Show To Get You Ready For The Stock Market Open, PreMarket Gainers, Earnings This Week, Economic Data & More! Benzinga PreMarket Prep 8:00AM ET- 9:00AM ET
#1 Morning Stock Show To Get You Ready For The Stock Market Open, PreMarket Gainers, Earnings This Week, Economic Data & More! Benzinga PreMarket Prep 8:00AM ET- 9:00AM ET
Report form
